Viewing StudyNCT00216593



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00216593
Status: COMPLETED
Last Update Posted: 2011-06-21
First Post: 2005-09-13

Brief Title: Treatment of Severe Alzheimers Disease Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study
Sponsor:
Organization: Janssen Pharmaceutica NV Belgium